富蘭克林坦伯頓全球投資系列-生技領航基金美元A(acc)股
44.56美元0.4(0.91%)
2024/07/25更新
績效 / 1月6.65%
3月15.53%
1年32.34%
晨星評等 - 1.現金0.27%
- 2.股票14.17%
- 3.債券0.00%
- 4.其他85.56%
- 1.美國83.78%
- 2.歐洲不包含歐元區4.85%
- 3.歐元區4.53%
- 4.英國3.82%
- 5.加拿大0.78%
- 1.Amgen Inc8.11%
- 2.Regeneron Pharmaceuticals Inc7.32%
- 3.Vertex Pharmaceuticals Inc6.25%
- 4.Ascendis Pharma A/S ADR3.89%
- 5.Insmed Inc3.69%
- 6.Biogen Inc3.37%
- 7.Merus NV3.31%
- 8.Gilead Sciences Inc3.13%
- 9.AstraZeneca PLC ADR2.97%
- 10.Intra-Cellular Therapies Inc2.75%
- 1.現金0.27%
- 2.股票14.17%
- 3.債券0.00%
- 4.其他85.56%
- 1.美國83.78%
- 2.歐洲不包含歐元區4.85%
- 3.歐元區4.53%
- 4.英國3.82%
- 5.加拿大0.78%
- 1.Amgen Inc8.11%
- 2.Regeneron Pharmaceuticals Inc7.32%
- 3.Vertex Pharmaceuticals Inc6.25%
- 4.Ascendis Pharma A/S ADR3.89%
- 5.Insmed Inc3.69%
- 6.Biogen Inc3.37%
- 7.Merus NV3.31%
- 8.Gilead Sciences Inc3.13%
- 9.AstraZeneca PLC ADR2.97%
- 10.Intra-Cellular Therapies Inc2.75%